BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND P2RY8, RP11-261P4_4, 286530, ENSG00000182162, MGC50878, P2Y8, Q86VZ1
67056 results:

  • 1. Immunotherapy for esophageal cancer: Where are we now and where can we go.
    Shoji Y; Koyanagi K; Kanamori K; Tajima K; Ogimi M; Ninomiya Y; Yamamoto M; Kazuno A; Nabeshima K; Nishi T; Mori M
    World J Gastroenterol; 2024 May; 30(19):2496-2501. PubMed ID: 38817664
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Risk of second primary thyroid cancer in cancer survivors.
    Yuan Y; Sun P; Xiao H; Li L; Li J; Ai X
    Sci Rep; 2024 May; 14(1):12478. PubMed ID: 38816510
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Salvage radiofrequency ablation followed by external beam radiotherapy for inoperable recurrent differentiated thyroid cancer.
    Chen CS; Luo SD; Chang YH; Chou CK; Chi SY; Wu SC; Chen YH; Yang JC; Huang EY; Wang YM; Lin WC
    Int J Hyperthermia; 2024; 41(1):2358054. PubMed ID: 38816274
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Interactions between LAMP3+ dendritic cells and T-cell subpopulations promote immune evasion in papillary thyroid carcinoma.
    Wang Z; Ji X; Zhang Y; Yang F; Su H; Zhang H; Li Z; Zhang W; Sun W
    J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38816233
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Thyroid Malignancy in Patients Who Underwent Thyroidectomy for Multinodular Goiter and Solitary Thyroid Nodule.
    Gedamu D; Shimels T; Kassie D; Chanyalew Z; Eyasu M
    JCO Glob Oncol; 2024 May; 10():e2300322. PubMed ID: 38815179
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. The Current Diagnostic Performance of MRI-Based Radiomics for Glioma Grading: A Meta-Analysis.
    De Maria L; Ponzio F; Cho HH; Skogen K; Tsougos I; Gasparini M; Zeppieri M; Ius T; Ugga L; Panciani PP; Fontanella MM; Brinjikji W; Agosti E
    J Integr Neurosci; 2024 May; 23(5):100. PubMed ID: 38812383
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. [Study on mechanism of inhibiting proliferation of head and neck cancer cells by citral, active ingredient of lemon essential oil].
    Chen L; Zhang YJ; Qin HW; Hu WJ; Liu YJ; Xiao GS; DU HH; Yang DL
    Zhongguo Zhong Yao Za Zhi; 2024 May; 49(9):2364-2375. PubMed ID: 38812137
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Lymph node metastasis in cutaneous squamous cell carcinoma of the head and neck.
    Fang Q; Yuan J; Zhang X; Dai L; Luo R
    BMC Cancer; 2024 May; 24(1):656. PubMed ID: 38811899
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Immune checkpoint inhibitors as the second-line treatment for advanced esophageal squamous cell carcinoma: a cost-effectiveness analysis based on network meta-analysis.
    Yang X; Zheng X; Hu S; Huang J; Zhang M; Huang P; Wang J
    BMC Cancer; 2024 May; 24(1):654. PubMed ID: 38811891
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Influence of maximum diameter on fine-needle aspiration biopsy outcomes in ACR TI-RADS 5 thyroid nodules.
    Cao SL; Shi WY; Niu YR; Zhao ZL; Wei Y; Wu J; Peng LL; Li Y; Yu MA
    Front Endocrinol (Lausanne); 2024; 15():1374888. PubMed ID: 38808118
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The efficacy and safety of dalpiciclib, a cyclin-dependent kinase 4/6 inhibitor, in patients with advanced head and neck mucosal melanoma harboring CDK4 amplification.
    Shi C; Ju H; Zhou R; Xu S; Wu Y; Gu Z; Wang Y; Chen W; Huang X; Han Y; Sun S; Li C; Wang M; Zhou G; Zhang Z; Li J; Ren G
    BMC Med; 2024 May; 22(1):215. PubMed ID: 38807144
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. FOXD2-AS1 promotes malignant cell behavior in oral squamous cell carcinoma via the miR-378 g/CRABP2 axis.
    Guo S; Huang B; You Z; Luo Z; Xu D; Zhang J; Lin J
    BMC Oral Health; 2024 May; 24(1):625. PubMed ID: 38807101
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Practical surgical technique using the SMISS approach for lip reduction in involuted lip infantile hemangiomas.
    Chen Q; Chang SJ; Gao W; Chang L; Qiu Y; Lin X
    BMC Pediatr; 2024 May; 24(1):368. PubMed ID: 38807073
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Oncological outcomes post transoral robotic surgery (TORS) for HPV-associated oropharyngeal squamous cell carcinoma, a single-centre retrospective Australian study.
    Kornfeld B; Taha A; Kyang L; Sim HW; Dewhurst S; McCloy R; Chin V; Earls P; Parker A; Leavers B; Forstner D; Floros P; Crawford J; Gallagher R
    J Robot Surg; 2024 May; 18(1):226. PubMed ID: 38806847
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Comprehensive analysis revealed P4Hs as new biomarkers for prognosis and immunotherapy in head and neck cancer.
    Zhou H; Lei Y; Luo J; Wang J; Peng L; Mou K; Xiang L; Luo Y
    Sci Rep; 2024 May; 14(1):12234. PubMed ID: 38806556
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Donafenib as neoadjuvant therapy in locally advanced thyroid cancer: protocol for the DONATHYCA phase II prospective single-arm trial in China.
    Yu J; Liu H; Wu Y
    BMJ Open; 2024 May; 14(5):e081090. PubMed ID: 38806431
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. [Our experience in the treatment of congenital nasal median heterotopias in children and an overview of various treatment tactics].
    Molodtsova EV; Yunusov AS; Daikhes NA; Polyakov DP; Korobkin AS; Larina OM
    Vestn Otorinolaringol; 2024; 89(2):28-32. PubMed ID: 38805460
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Expression of Glutathione Peroxidase4 in Patients with Esophageal Squamous Carcinoma and Its Impact on the Radiosensitivity of Esophageal Squamous Carcinoma.
    Chen C; Gu W; Shao Y; Zheng P; Jiang J
    Ann Clin Lab Sci; 2024 Mar; 54(2):160-169. PubMed ID: 38802161
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Study on carotid artery stenosis after radiotherapy for nasopharyngeal carcinoma.
    Song J; Lan L; Lv Y; Wen Y; Kang M; Wang R
    J Cancer Res Clin Oncol; 2024 May; 150(5):273. PubMed ID: 38795230
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Targeting NG2 relieves the resistance of BRAF-mutant thyroid cancer cells to BRAF inhibitors.
    Sui F; Wang G; Liu J; Yuan M; Chen P; Yao Y; Zhang S; Ji M; Hou P
    Cell Mol Life Sci; 2024 May; 81(1):238. PubMed ID: 38795180
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 3353.